Stryker (NYSE:SYK) Accounts Receivable

: $3,261 Mil (As of Jun. 2023)

View and export this data going back to 1988. Start your Free Trial

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Stryker's accounts receivables for the quarter that ended in Jun. 2023 was $3,261 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Stryker's Days Sales Outstanding for the quarter that ended in Jun. 2023 was 59.56.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Stryker's Net-Net Working Capital per share for the quarter that ended in Jun. 2023 was $-36.41.

Stryker Accounts Receivable Historical Data

The historical data trend for Stryker's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stryker Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Accounts Receivable

2,332.00

2,893.00

2,701.00

3,022.00

3,565.00

Stryker Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Accounts Receivable																3,145.00	3,103.00	3,565.00	3,215.00	3,261.00

Stryker Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Stryker Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Stryker's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	3261	/	4996	*	91
=	59.56

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Stryker's accounts receivable are only considered to be worth 75% of book value:

Stryker's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2023 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1478	+	0.75 * 3261	+	0.5 * 4593	-	20048
-	0	-	0)	/	379.778
=	-36.41

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Stryker Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Stryker's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Stryker (NYSE:SYK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stryker Corp (NYSE:SYK) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

SYK:Mexico SYK:Germany SYK:Germany S1YK34:Brazil SYK:Austria

Address

2825 Airview Boulevard, Kalamazoo, MI, USA, 49002

Website

https://www.stryker.com

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.

Executives

James Andrew Pierce	officer: Group President	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Spencer S Stiles	officer: Group President	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Giovanni Caforio	director	BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 & PROVINCELINE ROAD, LAWRENCEVILLE NJ 08543
Skeete Tatum Lisa M	director	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Robert S Fletcher	officer: VP, Chief Legal Officer	2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Viju Menon	officer: Group President	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Sherilyn S Mccoy	director	JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933
Rajeev Suri	director	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Mary K Brainerd	director	8170 33RD AVENUE SOUTH, BLOOMINGTON MN 55425
Graham A Mclean	officer: President, Asia-Pacific	1 CORPORATE AVENUE ROWVILLE, VICTORIA C3 3178
Glenn S Boehnlein	officer: Vice President, CFO	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
M Kathryn Fink	officer: VP, Global Human Resources	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Yin C Becker	officer: VP, Comm. & Public Affairs	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Bijoy Sagar	officer: VP, Chief Information Officer	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Michael Damon Hutchinson	officer: General Counsel	2825 AIRVIEW BLVD, KALAMAZOO MI 49002